Innovation Pharmaceuticals Inc (IPIX)

[baytdr]

Aspire is obligated to purchase up to 30 million dollars worth of IPIX shares, which at 70 cents would be almost 43,000,000 shares. Theoretically if they wanted to purchase them at lower prices they could easily pressure the SP by selling about 10% of the daily volume each day for three to five months which by some calculus would pay off nicely if IPIX exercises the purchase option before good trial results are released. Of course, the opposite result would happen if IPIX releases great trial results before exercising their option with Aspire. I think it would be a bad bet for Aspire to try to rig the market, but some may think the risk is worth the potential reward. It seems to me that the market for small cap bio has turned negative and each day nervous selling exceeds opportunistic buying by just a little bit so there is a mostly downward steady pressure on the stock. Selling begets selling kind of logic. That's my WAG anyway. Personally I've been adding lately and I'm eager for results.